Pharma Mar SA
Pharma Mar's GHG Emissions Data Preview
In 2025, Pharma Mar completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Pharma Mar has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature.  a | 0000000 |
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature.  a | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind Pharma Mar’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Pharma Mar’s data sources below and access millions more through our Disclosure Search.
Insights into Pharma Mar's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Pharma Mar amounted to 3,080 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Pharma Mar increased by 8.57%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
Pharma Mar's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Pharma Mar's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Pharma Mar were 1,296 metric tons of CO₂ equivalent (tCO₂e).a
Has Pharma Mar reduced its Scope 1 emissions over time?
Since 2021, Pharma Mar's Scope 1 emissions have decreased by 5.61%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2024), Pharma Mar's Scope 1 emissions decreased by 3.28%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Pharma Mar's Scope 2 emissions?
In 2025, Pharma Mar reported Scope 2 greenhouse gas (GHG) emissions of 559 tCO₂e using the market-based method and 1,784 tCO₂e using the location-based method.a
Has Pharma Mar reduced its Scope 2 emissions over time?
Since 2021, Pharma Mar's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 41.7%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2024), Pharma Mar's Scope 2 emissions (Location-Based) rose by 19.17% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
What methodology does Pharma Mar use for Scope 2 reporting?
In 2025, Pharma Mar reported its Scope 2 emissions using the market-based method and using the location-based method.a
Pharma Mar's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Pharma Mar's Value Chain Emissions
In 2025, Pharma Mar reported 13,581 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Pharma Mar includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
Pharma Mar's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Pharma Mar's Scope 3 emissions?
In 2025, Pharma Mar reported total Scope 3 emissions of 13,581 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Has Pharma Mar reduced its Scope 3 emissions over time?
Since 2021, Pharma Mar's Scope 3 emissionshave remained relatively stable, indicating that Pharma Mar's emissions have plateaued with no significant change in its value chain footprint.a
Compared to the previous year (2024), Pharma Mar's Scope 3 emissions decreased by 15.81%, highlighting the company's efforts to lower indirect emissions from its value chain.a
What categories of Scope 3 emissions does Pharma Mar disclose?
In 2025, Pharma Mar reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Pharma Mar's Scope 3 emissions?
In 2025, the largest contributors to Pharma Mar's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 6,110 tCO₂e (44.99%)
- Capital Goods (Cat. 2): 5,852 tCO₂e (43.09%)
- Employee Commuting (Cat. 7): 772 tCO₂e (5.68%)
Pharma Mar's Scope 3 Emissions by Categories
Insights into Pharma Mar’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Pharma Mar reported Scope 1 greenhouse gas (GHG) emissions of 1,296 tCO₂e and total revenues of USD 260 millions. This translates into an emissions intensity of 4.98 tCO₂e per millions USD.a
Pharma Mar's Scope 1 Emissions Intensity Compared to Peers
How does Pharma Mar's GHG emissions intensity compare to its peers?
In 2025, Pharma Mar reported a Scope 1 emissions intensity of 4.98 tCO₂e per millions USD. Compared to the peer group median of 5.18, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Pharma Mar rank on GHG emissions intensity within its industry?
In 2025, Pharma Mar ranked 12 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Pharma Mar is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
Insights into Pharma Mar's Total Carbon Footprint
In 2025, Pharma Mar reported a total carbon footprint of 16,661 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 12.17% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Pharma Mar's total carbon footprint was Scope 3 emissions, accounting for 81.51% of the company's total carbon footprint, followed by Scope 2 emissions at 10.71%.a